Low risk chlorine dioxide onsite generation system
US-2018273381-A1 · Sep 27, 2018 · US
US11242248B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11242248-B2 |
| Application number | US-201916400277-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 1, 2019 |
| Priority date | Aug 23, 2010 |
| Publication date | Feb 8, 2022 |
| Grant date | Feb 8, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods, kits, cartridges, and compounds related to generating chlorine dioxide by exposing ClO 2 − to at least one of an iron porphyrin catalyst or an iron porphyrazine catalyst are described.
Opening claim text (preview).
What is claimed is: 1. A cartridge comprising a housing and at least one of an iron porphyrin catalyst or an iron porphyrazine catalyst in the housing, wherein the cartridge is adapted to allow reactants to contact the at least one of an iron porphyrin catalyst or an iron porphyrazine catalyst, and the cartridge further comprises at least one of the reactants or a source of ClO 2 − in the housing, and the reactants comprise ClO 2 − . 2. The cartridge of claim 1 , wherein the iron porphyrin catalyst has a structure of formula I: wherein the a is the oxidation state II, III or IV of the Fe and R 1 , R 2 , R 3 , and R 4 are independently selected from the group consisting of TM2PyP, TM4PyP, TDMImP, and TDMBImp, which have a structure of formulas II, III, IV, and V, respectively: and at least one of R 5 , R 6 , R 7 , R 8 , R 9 , and R 10 are independently selected from the group consisting of H, methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl, CH 2 —(CH 2 ) n1 —CH 3 where n1=5-20, CH 2 —(CH 2 ) n2 —CH 2 —X where n2=0-20, —CH 2 (CO)—(CH 2 ) n3 —CH 2 —X where n3=0-20, —CH 2 —Ar—X, (CH 2 ) n —X, (CH 2 ) m Ar—X, (CH 2 ) m Ar—Y, (CH 2 ) n —Y, CH 2 CONH—Y; CH 2 COO—Y, CH 2 CO(CH 2 ) P —Y, (OCH 2 CH 2 ) m —Y, (OCH 2 CH 2 ) m —X; Y 2 —X, CH 2 CH 2 OCH 2 CH 2 OCH 2 CH 2 OCH 3 , —CH 2 CO 2 CH 2 CH 3 , alkyl, CH 2 CH 2 OCH 3 , CH 2 CH 2 OCH 2 CH 2 OCH 3 , (CH 2 ) n —X, (CH 2 ) n —Y, (CH 2 ) n Ar—X, (CH 2 ) n Ar—Y, CH 2 CH 2 OCH 2 CH 2 OCH 2 CH 2 OCH 3 , CH 2 CO 2 CH 2 CH 3 , (OCH 2 CH 2 ) m —X, (OCH 2 CH 2 ) m —Y, Y 2 —X, or Y 2 C(Z 1 ) 3 ; where Z 1 is CH 2 OCH 2 (CH 2 ) n X, CH 2 OCH 2 (CH 2 ) n Y, or (CH 2 ) n C(O)Y 2 C(Z 2 ) 3 ; Z 2 is CH 2 OCH 2 CH 2 C(O)Y 2 C(Z 4 ) 3 ; Z 4 is CH 2 OCH 2 CH 2 X or (CH 2 ) n C(O)—Y 2 —C(Z 5 ) 3 ; Z 5 is CH 2 OCH 2 CH 2 C(O)Y 2 C(Z 6 ) 3 ; Z 6 is CH 2 OCH 2 CH 2 C(O)O(CH 2 CH 2 O) m CH 2 CH 2 O, (CH 2 ) n OCH 2 C(CH 2 OH) 3 , (CH 2 ) n OCH 2 CH(CH 2 OH) 2 , (CH) n OCH 2 C(CH 2 OH) 2 (CH 3 ), (CH 2 ) n OCH 2 C[CH 2 OCH 2 C(CH 2 OH) 3 ] 3 , (CH 2 ) n OCH 2 C[CH 2 OCH 2 C(CH 2 O[CH 2 CH 2 O] m CH 2 CH 2 OX) 3 , CH 2 CONH—Y, CH 2 CO—Y, or CH 2 CO(CH 2 ) P —Y; where Ar is substituted or unsubstituted phenyl, substituted or unsubstituted biphenyl, or substituted or unsubstituted naphthyl and when Ar is the phenyl in —CH 2 —Ar—X, (CH 2 ) m Ar—X, or (CH 2 ) m Ar—Y, the X or Y is attached ortho- meta- or para to the —CH 2 — attached to pyridoporphyrazine; n is 1 to 10; m is 1 to 200; p is 1 or 2; X is COOH, COO(alkyl 1 ), CONH 2 , CONH(alkyl 1 ), CON(alkyl 1 ) 2 , CO(CH 2 ) P alkyl 1 , OPO 3 H 2 , PO 3 H 2 , SO 3 H, NH 2 , N(alkyl 1 ) 2 , or N(alkyl 1 ) 3 + , where alkyl 1 is methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, or octyl; Y is OH, (O—CH 2 CH 2 ) m —W 1 , or (CH 2 CH 2 ) m —W 2 , where W 1 is OH or (O—(CH 2 CH 2 ) m OH), and W 2 is O-alkyl; and Y 2 is —(CH 2 ) n O—, —(CH 2 ) n NH—, —(CH) n S—; CH 2 CONH—, CH 2 COO—, or CH 2 CO(CH 2 ) p —; and L 1 and L 2 are, independently absent, halide, oxo, aquo, hydroxo, CN, OPO 3 H, or alcohol. 3. The cartridge of claim 2 , wherein the alkyl is selected from straight-chain or branched-chain alkyl radicals containing from 1 to 22 carbon atoms, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, pentyl, iso-amyl, hexyl, octyl, nonyl, decyl, dodecyl, tetradecyl, hexadecyl, octadecyl, and eicosyl. 4. The cartridge of claim 2 , wherein R 1 , R 2 , R 3 , and R 4 are TDMBImp. 5. The cartridge of claim 2 , wherein R 1 , R 2 , R 3 , and R 4 are TM2PyP or R 1 , R 2 , R 3 and R 4 are TM4PyP. 6. The cartridge of claim 1 , wherein the iron porphyrazine catalyst has a structure of formula VI: wherein a is the oxidation state II, III or IV of the Fe and each of A 1 , A 2 , A 3 , A 4 , B 1 , B 2 , B 3 , B 4 , C 1 , C 2 , C 3 , C 4 , D 1 , D 2 , D 3 , and D 4 are independently selected from N + —R n , N, C—H, C—X, and C—R n ; when N + —R n is selected, only one in each set of A 1 , B 1 , C 1 , and D 1 ; A 2 , B 2 , C 2 , and D 2 ; A 3 , B 3 , C 3 , and D 3 ; or A 4 , B 4 , C 4 , and D 4 is N + —R n ; when N is selected, only one in each set of A 1 , B 1 , C 1 , and D 1 ; A 2 , B 2 , C 2 , and D 2 ; A 3 , B 3 , C 3 , and D 3 ; or A 4 , B 4 , C 4 , and D 4 is N; each R, is independently selected from the group consisting of H, methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl, CH 2 —(CH 2 ) n1 —CH 3 where n1=5-20, CH 2 —(CH 2 ) n2 —CH 2 —X where n2=0-20, CH 2 (CO)—(CH 2 ) n3 —CH 2 —X where n3=0-20, CH 2 —Ar—X, (CH 2 ) n —X; (CH 2 ) m Ar—X, (CH 2 ) m Ar—Y, (CH 2 ) n —Y, CH 2 CONH—Y; CH 2 COO—Y, CH 2 CO—Y, CH 2 CO(CH 2 ) P —Y, (OCH 2 CH 2 ) m —Y, (OCH 2 CH 2 ) m —X, Y 2 —X, CH 2 CH 2 OCH 2 CH 2 OCH 2 CH 2 OCH 3 , CH 2 CO 2 CH 2 CH 3 , CH 2 CH 2 OCH 3 , CH 2 CH 2 OCH 2 CH 2 OCH 3 , (CH 2 ) n —Y, (CH 2 ) n Ar—X, (CH 2 ) n Ar—Y, and Y 2 C(Z 1 ) 3 ; Z 1 is CH 2 OCH 2 (CH 2 ) n X, CH 2 OCH 2 (CH 2 ) n Y, or (CH 2 ),C(O)Y 2 C(Z 2 ) 3 ; Z 2 is CH 2 OCH 2 CH 2 C(O)Y 2 C(Z 3 ) 3 ; Z 3 is CH 2 OCH 2 CH 2 X or (CH 2 ) n C(O)—Y 2 —C(Z 4 ) 3 ; Z 4 is CH 2 OCH 2 CH 2 C(O)Y 2 C(Z 5 ) 3 ; and Z 5 is CH 2 OCH 2 CH 2 C(O)O(CH 2 CH 2 O) m CH 2 CH 2 O, (CH 2 ) n OCH 2 C(CH 2 OH) 3 , (CH 2 ) n OCH 2 CH(CH 2 OH) 2 , (CH 2 ) n OCH 2 C(CH 2 OH) 2 (CH 3 ), (CH 2 ) n OCH 2 C[CH 2 OCH 2 C(CH 2 OH) 3 ] 3 , (CH 2 ) n OCH 2 C[CH 2 OCH 2 C(CH 2 O[CH 2 CH 2 O] m CH 2 CH 2 OX) 3 , CH 2 CONH—Y, CH 2 CO—Y, or CH 2 CO(CH 2 ) P —Y; where Ar is substituted or unsubstituted phenyl, substituted or unsubstituted biphenyl, or substituted or unsubstituted naphthyl and when Ar is the phenyl in —CH 2 —Ar—X, (CH 2 ) m Ar—X, or (CH 2 ) m Ar—Y, the X or Y is attached ortho- meta- or para to the —CH 2 — attached to pyridoporphyrazine; n is 1 to 10; m is 1 to 200; p is 1 or 2; X is COOH, COO(alkyl 1 ), CONH 2 , CONH(alkyl 1 ), CON(alkyl 1 ) 2 , CO(CH 2 ) P alkyl 1 , OPO 3 H 2 , PO 3 H 2 , SO 3 H, NH 2 , N(alkyl 1 ) 2 , or N(alkyl 1 ) 3 + , where alkyl 1 is methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, or octyl; Y is OH, (O—CH 2 CH 2 ) m —W 1 , or (CH 2 CH 2 ) m —W 2 ; W 1 is OH or (O—(CH 2 CH 2 ) m OH); W 2 is O-alkyl; and Y 2 is —(CH 2 ) n O—, —(CH 2 ) n NH—, —(CH 2 ) n S—; CH 2 CONH—, CH 2 COO—, or CH 2 CO(CH 2 ) p —; and L 1 and L 2 are independently absent, halide, oxo, aquo, hydroxo, CN, OPO 3 H, or alcohol. 7. The cartridge of claim 6 , wherein in the O-alkyl the alkyl is selected from straight-chain or branched-chain alkyl radicals containing from 1 to 22 carbon atoms, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, pentyl, iso-amyl, hexyl, octyl, nonyl, decyl, dodecyl, tetradecyl, hexadecyl, octadecyl, and eicosyl. 8. The cartridge of claim 1 , wherein the cartridge comprises the reactants, and the reactants. 9. The cartridge of claim 8 , wherein the ClO 2 − is in the form of at least one substance selected from the group consisting of chlorite salts. 10. The cartridge of claim 8 , wherein the ClO 2 − is in the form of at least one substance selected from the group consisting of sodium chlorite, potassium chlorite, calcium chlorite and magnesium chlorite. 11. The cartridge of claim 8 , wherein the ClO 2 − is mixed with a solid filler. 12. The cartridge of claim 8 , wherein the ClO 2 − is adsorbed on at least one substance selected from the group consisting of clay, silica, alumina and organic polymers.
Iron · CPC title
with more than one complexing nitrogen atom, e.g. phenanthroline · CPC title
from chlorites · CPC title
with ClO2 or chlorites · CPC title
without a metal-carbon linkage · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.